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This standard is based on NG56.
This standard should be read in conjunction with QS86, QS136, QS132 and QS120.
Quality statements
Statement 1 Adults with multimorbidity are identified by their GP practice.
Statement 2 Adults with an individualised management plan for multimorbidity are given
opportunities to discuss their values, priorities and goals.
Statement 3 Adults with an individualised management plan for multimorbidity know who is
responsible for coordinating their care.
Statement 4 Adults having a review of their medicines and other treatments for multimorbidity
discuss whether any can be stopped or changed.
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NICE has developed guidance and quality standards on patient experience in adult NHS
services and service user experience in adult mental health services (see the NICE pathways
on patient experience in adult NHS services and service user experience in adult mental health
services), which should be considered alongside the quality statements on multimorbidity. The
quality standards on patient and service user experience include statements on shared
decision-making and coordination of care through the exchange of patient information, which
are particularly relevant to this quality standard on multimorbidity.
Other quality standards that should be considered when commissioning or providing
multimorbidity services include:
Falls in older people (2015, updated 2017) NICE quality standard 86.
Transition between inpatient hospital settings and community or care home settings for
adults with social care needs (2016) NICE quality standard 136. See quality statement 2 on
comprehensive geriatric assessment.
Social care for older people with multiple long-term conditions (2016) NICE quality
standard 132.
Medicines optimisation (2016) NICE quality standard 120.
A full list of NICE quality standards is available from the quality standards topic library.
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Quality statement 1: Identification
Quality statement
Adults with multimorbidity are identified by their GP practice.
Rationale
Identifying all adults with multimorbidity is the first step towards finding those who may benefit
from an approach to care that takes account of multimorbidity. Multimorbidity is often associated
with reduced quality of life, higher mortality, polypharmacy and high treatment burden, higher
rates of adverse drug events, and much greater health services use. Some people with
multimorbidity have conditions that significantly affect their everyday functioning. Some people
find that managing their care is burdensome and involves a number of services working in an
uncoordinated way.
Quality measures
Structure
Evidence that GP practices identify all adults with multimorbidity.
Data source: Local data collection from service protocols.
Process
Proportion of adults with multimorbidity identified by the GP practice.
Numerator – the number in the denominator identified as having multimorbidity by the GP
practice.
Denominator – the number of adults registered with the GP practice.
Data source: GP practice health records.
Outcome
Number of adults with multimorbidity identified by the GP practice who may benefit from an
approach to care that takes account of multimorbidity.
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Data source:GP practice health records.
What the quality statement means for different audiences
Service providers (GP practices) ensure that systems are in place to identify all adults with
multimorbidity. Identification may be opportunistic during routine care or involve a systematic
search of electronic health records.
Healthcare practitioners (such as GPs, practice nurses and practice managers) identify adults with
multimorbidity proactively using health records and opportunistically during routine care. They
record this information in health records.
Commissioners (clinical commissioning groups and NHS England) ensure that GP practices identify
all adults with multimorbidity and have monitoring arrangements that show this is being done.
Adults with more than 1 long-term health condition, including a physical condition, are identified by
their GP practice. The practice may do this by looking at health records or having discussions about
health problems during routine appointments.
Source guidance
Multimorbidity: clinical assessment and management (2016) NICE guideline NG56,
recommendation 1.3.1
Definitions of terms used in this quality statement
Adults with multimorbidity
Adults with multimorbidity have 2 or more long-term health conditions where at least 1 of these
conditions must be a physical health condition.
Long-term health conditions can include:
defined physical and mental health conditions such as diabetes or schizophrenia
ongoing conditions such as learning disability
symptom complexes such as frailty or chronic pain
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sensory impairment such as sight or hearing loss
alcohol and substance misuse.
People who have multiple mental health problems and no physical health conditions are not
included because their care will be largely delivered by psychiatric services.
[Adapted from NICE's guideline on multimorbidity, recommendation 1.1.1 and full guideline]
Identifying adults with multimorbidity
GP practices can identify adults with multimorbidity:
opportunistically during routine care
proactively using electronic health records.
[NICE's guideline on multimorbidity, recommendation 1.3.1]
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Quality statement 2: Assessing values, priorities and goals
Quality statement
Adults with an individualised management plan for multimorbidity are given opportunities to
discuss their values, priorities and goals.
Rationale
A person's values, priorities and goals can affect how they experience long-term health problems
and how these affect their life. They can also affect their need for care and support. Discussing and
exploring what is important to a person with multimorbidity, recording this in their individualised
management plan, and sharing the information can ensure that the planning and delivery of care
reflects personal preferences. A person's circumstances may change, so values, priorities and goals
should be reviewed and updated.
Quality measures
Structure
Evidence of local arrangements to ensure that adults with an individualised management plan for
multimorbidity are given opportunities to discuss their values, priorities and goals.
Data source: Local data collection from service protocols.
Process
Proportion of adults with an individualised management plan for multimorbidity whose plan has a
record of values, priorities and goals.
Numerator – the number in the denominator whose individualised management plan has a record
of values, priorities and goals.
Denominator – the number of adults with an individualised management plan for multimorbidity.
Data source: Audit of patient's individualised management plans.
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Outcome
Adults with an individualised management plan for multimorbidity feel that the decisions about
their treatment have taken into account their values, priorities and goals.
Data source:Patient survey.
What the quality statement means for different audiences
Service providers (such as GP practices, district nursing services, community pharmacies, hospitals)
ensure that staff providing care to adults with an individualised management plan for
multimorbidity give them opportunities to discuss values, priorities and goals, and record these in
the management plan.
Healthcare professionals (such as GPs, practice nurses, district nurses, community pharmacists)
give adults with an individualised management plan for multimorbidity opportunities to discuss
values, priorities and goals. They ask if the person would like a relative, friend or independent
advocate to join the discussion; they explore if the person has any advance care plans or other
preferences for care; they check throughout care if the person has any new or changed
preferences. They record the discussions in the person's individualised management plan.
Commissioners (clinical commissioning groups and NHS England) ensure that they commission
services that use individualised management plans to deliver and coordinate care for adults with
multimorbidity, and that these include up-to-date details of personal values, priorities and goals.
Adultswith a management plan for multimorbidity are given chances to discuss what is important
to them with a member of their care team. This includes their quality of life, their values, priorities
and future life goals. Discussions are recorded in the plan so that all those providing care can take
them into account.
Source guidance
Multimorbidity: clinical assessment and management (2016) NICE guideline NG56,
recommendation 1.6.7
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Definitions of terms used in this quality statement
Individualised management plan for multimorbidity
A plan for a person's care that takes account of multimorbidity based on personalised assessment.
The aim is to improve quality of life by reducing treatment burden, adverse events, and unplanned
or uncoordinated care. The plan includes a person's individual needs, preferences for treatments,
health priorities and lifestyle. It aims to improve coordination of care across services, particularly if
this has become fragmented.
[Adapted from NICE's guideline on multimorbidity]
Values, priorities and goals
These may include:
maintaining independence
undertaking paid or voluntary work, taking part in social activities and playing an active part in
family life
preventing specific adverse outcomes (for example, stroke)
reducing harms from medicines
reducing treatment burden
lengthening life.
[NICE's guideline on multimorbidity, recommendation 1.6.7]
Equality and diversity considerations
Healthcare professionals should take into account the needs of adults who are less able to
understand and express their values, priorities and goals (for example, those with learning
disabilities, cognitive impairment or language barriers). They should also assess a person's
knowledge, skills and confidence in managing their own health and care. Reasonable adjustments
should be made such as providing information in a format that suits their needs and preferences,
asking if a friend or relative should be involved, and providing access to an interpreter or advocate
if needed. For people with additional needs related to a disability, impairment or sensory loss,
information should be provided as set out in NHS England's accessible information standard.
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Quality statement 3: Coordination of care
Quality statement
Adults with an individualised management plan for multimorbidity know who is responsible for
coordinating their care.
Rationale
Managing multiple long-term conditions can be difficult because of the complexity of the
conditions and treatment options. An individualised management plan helps ensure that decisions
about optimising treatment take account of a person's preferences, needs and priorities; and that
the resulting actions are clear. A key aspect is agreement between the person with multimorbidity
and the healthcare professional about who is responsible for coordinating care. It is important that
the person feels comfortable with the decision and that this information is clearly recorded in the
management plan. This can then be shared with healthcare professionals, a partner, family
members and carers.
Quality measures
Structure
Evidence of local arrangements to ensure that adults with an individualised management plan for
multimorbidity know who is responsible for coordinating their care.
Data source: Local data collection from service specifications.
Process
Proportion of adults with an individualised management plan for multimorbidity whose plan states
who is responsible for coordinating their care.
Numerator – the number in the denominator whose individualised management plan states who is
responsible for coordinating their care.
Denominator – the number of adults with an individualised management plan for multimorbidity.
Data source: Audit of patient's individualised management plans.
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Outcome
a) Number of adults with an individualised management plan for multimorbidity who feel they were
involved in the discussion about who is responsible for coordinating their care.
Data source:Patient survey.
b) Number of adults with an individualised management plan for multimorbidity who know which
healthcare professional is coordinating their care.
Data source:Patient survey.
What the quality statement means for different audiences
Service providers (such as primary care services) ensure that systems are in place for adults with an
individualised management plan for multimorbidity to know who is responsible for coordinating
their care, and to record this in the individualised management plan.
Healthcare professionals (such as GPs, practice nurses and practice pharmacists) agree who is
responsible for coordinating care with adults with an individualised management plan for
multimorbidity. They record this in the management plan, and share the plan with the person and
(with the person's permission) other people involved in the care, including other healthcare
professionals, a partner, family members and carers.
Commissioners (clinical commissioning groups and NHS England) commission services in which
adults with an individualised management plan for multimorbidity know who is responsible for
coordinating their care and have this information recorded in the plan.
Adults with a management plan for multimorbidity are involved in deciding who is responsible for
coordinating their care. This is recorded in their plan and the plan is given to the person, and if they
wish, to family members and carers. Doing this will make sure everyone knows who will organise
different parts of the care so that they work well together.
Source guidance
Multimorbidity: clinical assessment and management (2016) NICE guideline NG56,
recommendation 1.5.2 and 1.6.17
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Definitions of terms used in this quality statement
Individualised management plan for multimorbidity
A plan for a person's care that takes account of multimorbidity based on personalised assessment.
The aim is to improve quality of life by reducing treatment burden, adverse events, and unplanned
or uncoordinated care. The plan includes a person's individual needs, preferences for treatments,
health priorities and lifestyle. It aims to improve coordination of care across services, particularly if
this has become fragmented.
[Adapted from NICE's guideline on multimorbidity]
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Quality statement 4: Reviewing medicines and other treatments
Quality statement
Adults having a review of their medicines and other treatments for multimorbidity discuss whether
any can be stopped or changed.
Rationale
Once preferences and priorities have been explored and any burdens of treatment understood, a
healthcare professional and patient can review medicines and other treatments and consider
whether they are serving a person's interests. This review might lead to treatments being stopped
or changed, or new treatments being started. A family member, friend, or independent advocate
may help a person to explain their preferences and better understand their choices. Discussions
should include agreement on how frequently future reviews should happen to take account of
changes in circumstances.
Quality measures
Structure
Evidence of local arrangements to ensure that adults having a review of their medicines and other
treatments for multimorbidity discuss whether any can be stopped or changed.
Data source: Local data collection from service protocols.
Process
Proportion of adults having a review of their medicines and other treatments for multimorbidity
who discussed whether any could be stopped or changed.
Numerator – the number in the denominator who discussed whether any treatments could be
stopped or changed.
Denominator – the number of adults having a review of their medicines and other treatments for
multimorbidity.
Data source: Audit of health records.
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Outcome
a) Number of adverse events from medicines in adults with multimorbidity.
Data source:Audit of health records.
b) Adults having a review of their medicines and other treatments for multimorbidity feel that the
decisions about their treatments have taken into account the outcomes they felt were important.
Data source:Patient survey.
c) Adults having a review of their medicines and other treatments for multimorbidity feel that their
treatment burden is reduced.
Data source:Patient survey.
What the quality statement means for different audiences
Service providers (such as primary care services) ensure that reviews of medicines and other
treatments for adults with multimorbidity include discussing whether any can be started, stopped
or changed and the frequency of future reviews.
Healthcare professionals (such as GPs and practice nurses) discuss with adults having a review of
their medicines and other treatments for multimorbidity whether any can be stopped or changed
to better serve the person's interest. They agree a frequency for ongoing reviews and record this in
the individualised management plan.
Commissioners (clinical commissioning groups and NHS England) commission services in which
adults having a review of their medicines and other treatments for multimorbidity discuss whether
any can be started, stopped or changed and the frequency of future reviews.
Adults with multimorbidity who are having a review of their treatments with their GP or practice
nurse discuss if some treatments can be stopped or changed. The aim of this is to improve the
person's quality of life.
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Source guidance
Multimorbidity: clinical assessment and management (2016) NICE guideline NG56,
recommendations 1.5.2 and 1.6.11
Definitions of terms used in this quality statement
Review of their medicines and other treatments for multimorbidity
A review of medicines and non-pharmacological treatments, such as diets and exercise
programmes, that takes account of likely benefits and harms for the individual patient, and
outcomes for the patient.
[Adapted from NICE's guideline on multimorbidity, recommendation 1.5.2 and full guideline]
Multimorbidity
The presence of 2 or more long-term health conditions where at least 1 of these conditions must be
a physical health condition.
Long-term health conditions can include:
defined physical and mental health conditions such as diabetes or schizophrenia
ongoing conditions such as learning disability
symptom complexes such as frailty or chronic pain
sensory impairment such as sight or hearing loss
alcohol and substance misuse.
Multiple mental health problems and no physical health conditions are not included. Care for
people with only mental health problems would largely be delivered by psychiatric services and is
not covered by this quality standard.
[Adapted from NICE's guideline on multimorbidity, recommendation 1.1.1 and full guideline]
Stopped or changed
Stopping, changing or starting of medicines and non-pharmacological treatments.
Multimorbidity (QS153)
© NICE 2017. All rights reserved. Page 17 of 21
[Adapted from NICE's guideline on multimorbidity, recommendations 1.6.11 and 1.6.15]
Equality and diversity considerations
Healthcare professionals should take into account the needs of adults who may find it difficult to
fully participate in a review of medicines and other treatments (for example, those with learning
disabilities, cognitive impairment or language barriers). They should also assess a person's
knowledge, skills and confidence in managing their own health and care. Reasonable adjustments
should be made such as providing information in a format that suits their needs and preferences,
and providing access to an interpreter or advocate if needed. For people with additional needs
related to a disability, impairment or sensory loss, information should be provided as set out in NHS
England's accessible information standard.
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About this quality standard
NICE quality standards describe high-priority areas for quality improvement in a defined care or
service area. Each standard consists of a prioritised set of specific, concise and measurable
statements. NICE quality standards draw on existing NICE or NICE-accredited guidance that
provides an underpinning, comprehensive set of recommendations, and are designed to support
the measurement of improvement.
Information about how NICE quality standards are developed is available from the NICE website.
See quality standard advisory committees on the website for details of standing committee 3
members who advised on this quality standard. Information about the topic experts invited to join
the standing members is available on the quality standard's webpage.
This quality standard has been incorporated into the NICE pathway on multimorbidity.
NICE has produced a quality standard service improvement template to help providers make an
initial assessment of their service compared with a selection of quality statements. This tool is
updated monthly to include new quality standards.
NICE produces guidance, standards and information on commissioning and providing high-quality
healthcare, social care, and public health services. We have agreements to provide certain NICE
services to Wales, Scotland and Northern Ireland. Decisions on how NICE guidance and other
products apply in those countries are made by ministers in the Welsh government, Scottish
government, and Northern Ireland Executive. NICE guidance or other products may include
references to organisations or people responsible for commissioning or providing care that may be
relevant only to England.
Improving outcomes
This quality standard is expected to contribute to improvements in the following outcomes:
health-related quality of life for adults with multimorbidity
adults with multimorbidity feeling involved in decisions about their care
effects of health problems and treatment on day-to-day activities of adults with
multimorbidity.
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It is also expected to support delivery of the Department of Health's outcome frameworks:
Adult social care outcomes framework 2015–16
NHS outcomes framework 2016–17.
Resource impact
NICE quality standards should be achievable by local services. The potential resource impact is
considered by the quality standards advisory committee, drawing on resource impact work for the
source guidance. Organisations are encouraged to refer to the resource impact statement for the
source guidance.
Diversity, equality and language
During the development of this quality standard, equality issues were considered and equality
assessments are available. Any specific issues identified during development of the quality
statements are highlighted in each statement.
Commissioners and providers should aim to achieve the quality standard in their local context, in
light of their duties to have due regard to the need to eliminate unlawful discrimination, advance
equality of opportunity and foster good relations. Nothing in this quality standard should be
interpreted in a way that would be inconsistent with compliance with those duties.
ISBN: 978-1-4731-2541-4
Endorsing organisations
This quality standard has been endorsed by the following organisations, as required by the Health
and Social Care Act (2012):
• Department of Health
• NHS England
Supporting organisations
Many organisations share NICE's commitment to quality improvement using evidence-based
guidance. The following supporting organisations have recognised the benefit of the quality
standard in improving care for patients, carers, service users and members of the public. They have
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agreed to work with NICE to ensure that those commissioning or providing services are made
aware of and encouraged to use the quality standard.
• Royal College of Nursing
• British Geriatrics Society
• Older People’s Advocacy Alliance
• Royal Pharmaceutical Society
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